If you aren’t sharing data with a sense of urgency, you are missing the point. Cancer & rare disease patients live in the now. They don’t have time to wait for you to publish a paper. This is not about you. It’s about them. #CuresNotCredit

I’m at @Ask_Spectrum . There’s a line of grumpy customers but the manager is “supervising” instead of helping the next customer. I’ve been here almost an hour, others longer. Most just trying to cancel their services but they have to harass everyone first. Terrible experience.

My better half is out improving education today.

You know what @Apple announcement I would get excited about? Contacts. All the random software updates are nice, but can you please just make Contacts work correctly? #userexperience

Thanks so much to the College of American Pathologists for having me out to speak at their conference yesterday! #pathdata #InflateAwareness

Neu et al. reported that IORT after brain metastasis surgery achieved comparable survival and local control to HSRT, but with markedly lower 2-year radionecrosis rates (8.5% vs 53.2%). No symptomatic RN occurred in IORT patients w/o prior brain RT. #JNO https://t.co/OCNI7bmjqL

I know my feed is a little skewed but I’m truly curious: when you read an obituary that just says a person died from cancer (without naming a type), what does that make you think?

I don’t know who needs to hear this, but having cancer is not a stigma and is no one’s fault.

Learn more about Boltz-2, the new open source AI model from MIT and Recursion capable of predicting protein binding affinity with unprecedented speed, scale and accuracy. ▪️ Boltz-2 is the first model to combine structure and binding affinity prediction, approaching the accuracy

We are HIRING a talented #medstud for a research year @OU_Neurosurgery! ONLY open to current M3s in US MD programs planning to apply in #nsgy '26-27. Fantastic clinical & scholarly opportunity w our entire faculty & resident team, plz apply here: https://t.co/Q3Nqq4m7U7

May is Brain Tumor Awareness Month, something that my family feels the impact of every day - @AmandaHaddock @beadragonmaster https://t.co/xEz1IfzRiw #BrainTumor #AwarenessMonth #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews @CancerWorldmag

ISPNO 2026 now just over a year away! We will be attending PedSNO - come visit for a chance at complimentary registration!!

Clara sparked a mission to tear down barriers in pediatric cancer research. Because of her courage, @BTACFoundation is making it happen. Clara was brave—now we must be. #ThisIsWhy #BrainTumorAwarenessMonth

Join me and my friends at @BrainTumourRsch in lighting a candle for #BrainTumor #Awareness month and Brain Tumor #Research #ShineALight #BrainTumorAwarenessMonth #BrainTumorResearch

You can honor a loved one impacted by brain tumors during Gray Ribbon Giving Day on May 15th—add your dedication and their name will be included in our Honor Wall tribute. Learn More: https://t.co/dl4taz9qgt #GrayRibbonGivingDay #BrainTumorAwarenessMonth #GoGreyInMay #BTN

Behind every breakthrough is a child. This #BrainTumorAwarenessMonth, we honor the kids and families whose contributions fuel the research—and the reason we keep going. #PediatricResearch #KidsFirstDRC

Excited to see our latest study on the immune landscape of pediatric high-grade glioma patients out! Tweetorial from fabulous @BeccaBeccaDaria below 👇🏻, we hope this will useful to many in the field! @DFBC_PedCare @BostonChildrens @DanaFarber @broadinstitute #endbraincancer

Would love to see the data on ages 0-15. “People under 50” would imply that group as well. Maybe it should say “Adults under 50”?

#BrainTumorAwarenessMonth

In response to the urgent need for skilled scientists committed to cancer research, NCI seeks career development applications from early-career scientists conducting #CancerResearch in global settings 🌏. See Notice for application due dates ⏰ ➡️ https://t.co/IxpCtBaPeo

Although they are relatively rare, brain and spinal cord tumors are the most prevalent cancer among adolescents and young adults (AYAs) between the ages of 15 and 39 years old. A recent report highlights key trends in this population. https://t.co/4fhBfHJ3y2 #AYAcsm #CNStumors